3SBio Announces Strong 2026 Results and Global Expansion Efforts

3S Bio, a biopharmaceutical company based in China, has reported its interim results for the first half of 2026. The company recorded revenue of RMB 4.53 billion, marking a 3.9% year-over-year growth.…

Source